Modern Clinical Mycobacterium tuberculosis Strains Leverage Type I IFN Pathway for a Proinflammatory Response in the Host. Shankaran D, Arumugam P, Vasanthakumar RP, Singh A, et al. J Immunol 2022 Sep 23. pii: jimmunol.2101029. doi: 10.4049/jimmunol.2101029.

Read + Share

Amedeo Smart

Independent Medical Education

Shankaran D, Arumugam P, Vasanthakumar RP, Singh A, et al. Modern Clinical Mycobacterium tuberculosis Strains Leverage Type I IFN Pathway for a Proinflammatory Response in the Host. J Immunol 2022 Sep 23. pii: jimmunol.2101029. doi: 10.4049/jimmunol.2101029.
PMID: 36150728